查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499393

基于电动车的液态切片市场：按类型、应用和最终用户划分 - 2024-2030 年全球预测

EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年基于EV的液态切片市场规模为4.0​​966亿美元，预计2024年将达到4.7312亿美元，2030年将达到11.508亿美元，复合年增长率为15.89%。

基于 EV 的液态切片包括从体液中提取和分析细胞外囊泡 (EV)，代表了非侵入性癌症诊断和监测的开拓前缘。 EV是细胞释放的脂质结合颗粒，含有丰富的分子讯息，如DNA、RNA和蛋白质，反映了其来源细胞的健康状况。推动基于 EV 的液态切片的关键因素包括其非侵入性、早期癌症检测的潜力、监测疾病进展和治疗反应的能力以及提供肿瘤异质性洞察的能力。然而，这项新兴技术面临挑战，例如需要标准化的 EV 分离和分析方法、检测低丰度 EV 的灵敏度以及解释所获得的资料的复杂性。解决这些限制需要进行严格的研究来建立统一的通讯协定，进步分析技术以提高敏感性和特异性，以及用于资料解释的复杂的生物资讯工具。研究表明，用于即时监测的照护现场设备的开发、与人工智慧的整合进行预测分析以及扩展到癌症以外的其他疾病正在推动基于 EV 的液态切片在个性化医疗和诊断领域的使用。 。

主要市场统计
基准年[2023] 40966万美元
预测年份 [2024] 473.12 百万美元
预测年份 [2030] 11.508 亿美元
复合年增长率（%） 15.89%

区域洞察

美国，特别是美国，由于对医疗保健研发的大量投资以及 FDA主导的强大法规结构，先进诊断解决方案（包括基于 EV 的液态切片）的采用率很高。这种环境培育了竞争格局，许多生技公司和新兴企业在电动车研究和诊断方面处于领先地位。在医疗成本上升、患者意识提高和癌症盛行率上升的推动下，以中国和日本等国家主导的亚太地区基于 EV 的液态切片行业正在经历显着增长。该地区在政府优惠政策的支持下，专注于基于电动车的创新诊断设备的使用、生产和开发。然而，由于各国地理和经济差异很大，该地区的市场有些分散。欧洲、中东和非洲地区拥有成熟市场和新兴市场的均衡组合，其中西欧在采用基于 EV 的液态切片技术方面处于领先地位，并得到强大的医疗保健系统和对非侵入性诊断的高度认识的支持。随着公共和私人投资的涌入，加强医疗基础设施和服务，中东和非洲市场逐渐恢復步伐。

FPNV定位矩阵

FPNV 定位矩阵对于评估基于 EV 的液态切片市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对基于电动车的液态切片市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对基于 EV 的液态切片市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症盛行率和早期疗育的必要性
      • 对非侵入性诊断程序的偏好日益增加
    • 抑制因素
      • 基于EV的液态切片技术高成本
    • 机会
      • 基于 EV 的液态切片程序的进展
      • 政府对液态生物检体的有利核准
    • 任务
      • 进行基于 EV 的液态切片时的技术问题
  • 市场区隔分析
    • 类型：检测试剂套件的兴起作为临床诊断的基本标准化方法
    • 最终用户：学术研究实验室采用基于 EV 的液态切片进行药物开发和个人化医疗
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章基于电动车的液态切片市场：按类型

  • 检测套件
  • 装置
  • 服务

第七章基于 EV 的液态切片市场：按应用分类

  • 早期癌症筛检
  • 復发监测
  • 治疗方法选择
  • 治疗监测

第八章基于电动车的液态切片市场：按最终用户分类

  • 学术研究所
  • 临床实验室
  • 製药和生物技术公司

第9章：美洲基于电动车的液态切片市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区基于电动车的液态切片市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲基于EV的液态切片市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Quest Diagnostics 完成对 Haystack Oncology 的收购，将敏感的 MRD液态生物检体技术添加到癌症诊断产品组合中
    • Agena Bioscience 和 nRichDX 宣布建立商业合作伙伴关係，共同开发液态生物检体检体提取和检测解决方案
    • Mercy Bioanalytics 在 A 轮资金筹措中筹集了 4,100 万美元，用于开发用于早期癌症检测的新 Mercy Halo液态生物检体平台
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-2E76C3E47F69

[183 Pages Report] The EV-Based Liquid Biopsy Market size was estimated at USD 409.66 million in 2023 and expected to reach USD 473.12 million in 2024, at a CAGR 15.89% to reach USD 1,150.80 million by 2030.

EV-based liquid biopsy, encompassing the extraction and analysis of extracellular vesicles (EVs) from bodily fluids, represents a pioneering frontier in non-invasive cancer diagnostics and monitoring. EVs, which are lipid-bound particles released from cells, carry a wealth of molecular information, such as DNA, RNA, and proteins, reflective of the health status of their cells of origin. The major factors propelling the use of EV-based liquid biopsies include their non-invasive nature, the potential for early cancer detection, the capability to monitor disease progression and treatment response, and the ability to provide insights into tumor heterogeneity. Nevertheless, this nascent technology faces challenges such as the need for standardized methods for EV isolation and analysis, sensitivity in detecting low-abundance EVs, and the interpretive complexity of the data obtained. Addressing these restraints requires rigorous research to establish uniform protocols, advances in analytical technologies to enhance sensitivity and specificity, and sophisticated bioinformatics tools for data interpretation. The development of point-of-care devices for real-time monitoring, integration with artificial intelligence for predictive analytics, and expansion into other diseases beyond cancer illustrate EV-based liquid biopsy's profound impact on personalized medicine and diagnostic landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 409.66 million
Estimated Year [2024] USD 473.12 million
Forecast Year [2030] USD 1,150.80 million
CAGR (%) 15.89%

Regional Insights

In the Americas, particularly the United States, there's a high adoption rate of advanced diagnostic solutions, including EV-based liquid biopsies, driven by substantial investments in healthcare R&D and a robust regulatory framework spearheaded by the FDA. This environment fosters a competitive market landscape, with numerous biotech firms and startups pioneering in EV research and diagnostics. The APAC region, led by countries such as China and Japan, is witnessing major growth in the EV-based liquid biopsy sector, attributed to increasing healthcare expenditure, rising patient awareness, and escalating prevalence of cancer. The region's focus is on the use, production, and development of innovative EV-based diagnostics supported by favorable government policies. However, the market here is somewhat fragmented owing to the vast geographical and economic diversities between countries. The EMEA region demonstrates a balanced mix of mature and emerging markets, with Western Europe at the forefront of adopting EV-based liquid biopsy techniques, backed by strong healthcare systems and high awareness about non-invasive diagnostic methods. The Middle Eastern and African markets are gradually picking up pace, with investments flowing in from public and private sectors to enhance healthcare infrastructure and services.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the EV-Based Liquid Biopsy Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Prevalence of cancer and need for early intervention
      • Increasing preference for non-invasive diagnostic procedures
    • Market Restraints
      • High cost of EV-based liquid biopsy technologies
    • Market Opportunities
      • Advancements in EV-based liquid biopsy procedures
      • Favorable government approvals for liquid biopsy
    • Market Challenges
      • Technical complications of performing EV-based liquid biopsy
  • Market Segmentation Analysis
    • Type: Rise of assay kits as a standardized approach crucial for clinical diagnostics
    • End User: Adoption of EV-based liquid biopsy in academic and research laboratories for drug development and personalized medicine
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the EV-Based Liquid Biopsy Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the EV-Based Liquid Biopsy Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Quest Diagnostics Completes Acquisition of Haystack Oncology, Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio

Quest Diagnostics announces the successful completion of its acquisition of Haystack Oncology. This strategic move enriches Quest's portfolio with Haystack Oncology's minimal-residual disease (MRD) testing technology. Leveraging circulating tumor DNA (ctDNA), this advanced MRD testing technology significantly enhances the early detection capabilities for residual or recurring cancers, offering a transformative approach to guiding therapy choices. Quest Diagnostics plans to integrate this cutting-edge technology into developing novel blood-based laboratory services tailored for solid tumor cancers, marking a significant advancement in cancer diagnosis and treatment. [Published On: 2023-06-21]

Agena Bioscience and nRichDX Announce a Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes

Agena Bioscience has solidified its partnership with nRichDX, transitioning from a technical collaboration to a commercial alliance to promote its products within the research community. This partnership heralds significant advancements by coupling Agena's MassARRAY technology with nRichDX's Revolution Sample Prep System, a combination poised to redefine the landscape of liquid biopsy applications. The Revolution Sample Prep System stands out by consistently achieving higher yield extraction of these elusive variant transcripts from bodily fluids, elevating the MassARRAY platform's sensitivity threshold for detecting rare genetic markers in cancer. [Published On: 2023-04-14]

Mercy BioAnalytics Raises USD 41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection

Mercy BioAnalytics, Inc., an innovator in cancer detection through extracellular vesicle-based liquid biopsies, announced the successful closure of a notable USD 41 million in Series A funding. This achievement was led by Novalis LifeSciences and received robust support from a prestigious assembly of investors, including Sozo Ventures, Hatteras Venture Partners, iSelect Fund, American Cancer Society BrightEdge, and Broadway Angels. The investment aims to further the development of Mercy BioAnalytics' Mercy Halo platform, which stands out for its exceptional clinical sensitivity and specificity. [Published On: 2023-04-03]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the EV-Based Liquid Biopsy Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the EV-Based Liquid Biopsy Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agena Bioscience, Agilent Technologies, Inc., ALS Automated Lab Solutions GmbH, ANGLE PLC, Bio-Rad Laboratories, Inc, Bio-Techne Corporation, BioFluidica, Biological Dynamics, Bristol-Myers Squibb, C.H. Boehringer Sohn AG & Co. KG, Clinomics Europe Ltd., Corning Incorporated, ExosomeDx, Horiba Ltd., Illumina, Inc., Lonza Group Ltd., Malvern Panalytical Ltd., Mercy BioAnalytics, Inc., MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH, Mursla Bio, Nanostics Inc., PerkinElmer, Inc., Qiagen N.V., Quest Diagnostics, System Biosciences, LLC, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the EV-Based Liquid Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Assay Kits
    • Instruments
    • Services
  • Application
    • Early Cancer Screening
    • Recurrence Monitoring
    • Therapy Selection
    • Treatment Monitoring
  • End User
    • Academic & Research Institutes
    • Clinical Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cancer and need for early intervention
      • 5.1.1.2. Increasing preference for non-invasive diagnostic procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of EV-based liquid biopsy technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in EV-based liquid biopsy procedures
      • 5.1.3.2. Favorable government approvals for liquid biopsy
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complications of performing EV-based liquid biopsy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rise of assay kits as a standardized approach crucial for clinical diagnostics
    • 5.2.2. End User: Adoption of EV-based liquid biopsy in academic and research laboratories for drug development and personalized medicine
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. EV-Based Liquid Biopsy Market, by Type

  • 6.1. Introduction
  • 6.2. Assay Kits
  • 6.3. Instruments
  • 6.4. Services

7. EV-Based Liquid Biopsy Market, by Application

  • 7.1. Introduction
  • 7.2. Early Cancer Screening
  • 7.3. Recurrence Monitoring
  • 7.4. Therapy Selection
  • 7.5. Treatment Monitoring

8. EV-Based Liquid Biopsy Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Clinical Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas EV-Based Liquid Biopsy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific EV-Based Liquid Biopsy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa EV-Based Liquid Biopsy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Quest Diagnostics Completes Acquisition of Haystack Oncology, Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio
    • 12.3.2. Agena Bioscience and nRichDX Announce a Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes
    • 12.3.3. Mercy BioAnalytics Raises USD 41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EV-BASED LIQUID BIOPSY MARKET RESEARCH PROCESS
  • FIGURE 2. EV-BASED LIQUID BIOPSY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EV-BASED LIQUID BIOPSY MARKET DYNAMICS
  • FIGURE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EV-BASED LIQUID BIOPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 287. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023